Glycosylation Inhibitor Development

Glycosylation Inhibitor Development

Glycosylation Inhibitor Development Services at CD BioGlyco

The role of glycosylation is vital in various life processes, such as cell growth and reproduction, adhesion, and signal transduction. Abnormal glycosylation usually leads to the occurrence of some diseases. Therefore, the research of glycosylation has become a hot spot both in fundamental science and clinical applications. At CD BioGlyco, our advanced glycosylation inhibitor development services closely follow the development trend in science and technology. We aim to provide clients with unparalleled support services for glycosylation research. Our team of scientists has many years of experience in the development of glycosylation inhibitors. Our glycosylation inhibitor development services include but are not limited to the following directions.

Applications

  • The development of compounds that intervene in the glycosylation process provides new ideas for new drug development.
  • Glycosylation inhibitors serve as probes for altering cell and tissue glycosylation.
  • Inhibitors of glycosylation can be used to research the action of individual enzymes.

Exo- and endo-acting glycoside hydrolases can be inhibited by carbohydrate-based and medicinal chemistry-based inhibitorsFig.1 Exo- and endo-acting glycoside hydrolases can be inhibited by carbohydrate-based and medicinal chemistry-based inhibitors. (Gloster & Vocadlo, 2012)

Advantages of Us

  • We have top-notch technology with a leading level of technical strength.
  • We design compounds with a high degree of specificity while ensuring that they maintain their stability and activity in a variety of environments.
  • By deeply analyzing and mining this data, we gain key insights and information to guide our drug design and development process.

CD BioGlyco provides systematic overall solutions for the development of glycosylation inhibitors. Our experimental schemes are formulated by experts with many years of experience in this field. Our broad vision can provide customers with professional and high-quality help for scientific research projects.

Clients can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.

Reference

  1. Gloster, T.M.; Vocadlo, D.J. Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nature chemical biology. 2012, 8: 683-694.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.